A flexible, scaled and integrated e-Health educational and psychosocial services program that guarantees correct screening, monitoring and support in health education, adherence to treatments, and the provision of emotional care and psychosocial cancer quality.
An effective tool for drug screening in heart disease models. Regenerative medicine for the treatment of heart disease. A potential biological patch for post-infarct scars. A new technology for the generation of mature human cardiomyocytes.
New strategy to inhibit RANK pathway for the treatment of TNBC. RANK is expressed in 40% of TNBC where it was linked with poor clinical outcomes. Cost-effective therapy for TNBC and NSCLC easing the economic burden.
An attempt to restore the immune homeostasis from patients suffering from immune-inflammatory processes such as GvHD, autoimmune diseases and transplant rejection. This physiological immunomodulator overcomes the side effects of the present immunosuppressive and anti-inflammatory drugs, and enables to perform pharmacological therapy.